Burning Rock Biotech (BNR) Net Income towards Common Stockholders (2019 - 2025)

Burning Rock Biotech's Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$2.2 million for Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders rose 80.57% year-over-year to -$2.2 million; the TTM figure through Dec 2025 stood at -$7.8 million (up 83.85% YoY), while the FY2025 annual figure was -$2.2 million, up 80.83% from the prior year.
• Net Income towards Common Stockholders was -$2.2 million for Q4 2025 at Burning Rock Biotech, up from -$2.4 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$1.4 million in Q2 2025 to a low of -$41.2 million in Q1 2022.
• Historically, Net Income towards Common Stockholders has averaged -$20.8 million across 5 years, with a median of -$23.4 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Net Income towards Common Stockholders sank 131.53% in 2021, then jumped 90.89% in 2025.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$39.4 million in 2021, then climbed by 20.45% to -$31.4 million in 2022, then advanced by 27.12% to -$22.8 million in 2023, then soared by 50.47% to -$11.3 million in 2024, then surged by 80.57% to -$2.2 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$2.2 million (Q4 2025), -$2.4 million (Q3 2025), and -$1.4 million (Q2 2025), per Business Quant data.